Spire Wealth Management Reduces Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Spire Wealth Management lessened its position in IQVIA Holdings Inc. (NYSE:IQVFree Report) by 93.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 931 shares of the medical research company’s stock after selling 12,767 shares during the quarter. Spire Wealth Management’s holdings in IQVIA were worth $183,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Mutual Advisors LLC grew its stake in shares of IQVIA by 3.1% during the second quarter. Mutual Advisors LLC now owns 1,602 shares of the medical research company’s stock valued at $360,000 after buying an additional 48 shares during the last quarter. Parkside Financial Bank & Trust grew its stake in shares of IQVIA by 19.6% during the second quarter. Parkside Financial Bank & Trust now owns 293 shares of the medical research company’s stock valued at $66,000 after buying an additional 48 shares during the last quarter. Private Advisor Group LLC grew its stake in shares of IQVIA by 1.2% during the third quarter. Private Advisor Group LLC now owns 4,818 shares of the medical research company’s stock valued at $948,000 after buying an additional 56 shares during the last quarter. Penserra Capital Management LLC grew its stake in shares of IQVIA by 6.1% during the fourth quarter. Penserra Capital Management LLC now owns 971 shares of the medical research company’s stock valued at $198,000 after buying an additional 56 shares during the last quarter. Finally, Glassman Wealth Services grew its stake in shares of IQVIA by 21.3% during the second quarter. Glassman Wealth Services now owns 342 shares of the medical research company’s stock valued at $77,000 after buying an additional 60 shares during the last quarter. Institutional investors own 86.82% of the company’s stock.

Insider Activity

In other news, insider Kevin C. Knightly sold 13,117 shares of IQVIA stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $214.03, for a total transaction of $2,807,431.51. Following the completion of the transaction, the insider now directly owns 7,347 shares in the company, valued at $1,572,478.41. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.50% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the company. StockNews.com cut IQVIA from a “buy” rating to a “hold” rating in a research note on Thursday. JPMorgan Chase & Co. dropped their target price on shares of IQVIA from $262.00 to $239.00 and set an “overweight” rating for the company in a report on Monday, November 13th. Barclays increased their target price on shares of IQVIA from $215.00 to $260.00 and gave the stock an “overweight” rating in a report on Thursday, January 25th. Citigroup increased their target price on shares of IQVIA from $190.00 to $225.00 and gave the stock a “neutral” rating in a report on Monday, December 11th. Finally, Guggenheim dropped their target price on shares of IQVIA from $253.00 to $220.00 and set a “buy” rating for the company in a report on Friday, November 3rd. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $244.31.

Read Our Latest Report on IQVIA

IQVIA Stock Performance

Shares of IQV opened at $218.20 on Friday. The company has a 50-day simple moving average of $219.68 and a two-hundred day simple moving average of $211.31. IQVIA Holdings Inc. has a one year low of $167.42 and a one year high of $234.92. The firm has a market capitalization of $39.82 billion, a PE ratio of 36.67, a price-to-earnings-growth ratio of 2.49 and a beta of 1.48. The company has a debt-to-equity ratio of 2.12, a current ratio of 0.79 and a quick ratio of 0.79.

About IQVIA

(Free Report)

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Read More

Institutional Ownership by Quarter for IQVIA (NYSE:IQV)

Receive News & Ratings for IQVIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQVIA and related companies with MarketBeat.com's FREE daily email newsletter.